Tags

Type your tag names separated by a space and hit enter

Management of Urinary Incontinence With Underactive Bladder: A Review.
Int Neurourol J. 2020 Jun; 24(2):111-117.IN

Abstract

Urinary incontinence is caused by storage function failure, while underactive bladder (UAB) is caused by a decline in detrusor contractility and voiding dysfunction. As the treatment mechanisms for incontinence and UAB are contrary to each other, it is difficult to treat both incontinence and UAB, and the patient's quality of life can be further degraded. Conventional midurethral sling (MUS), such as transobturator tape or retropubic MUS, introduces a risk of postoperative voiding dysfunction in stress urinary incontinence with UAB. However, there have been several reports about the efficacy and safety of conventional MUS. Adjustable sling procedures, such as transobturator adjustable tape or the Remeex system, have better outcomes than conventional MUS because they control tension both during and after surgery. When voiding dysfunction occurs after incontinence treatment with UAB, voiding symptoms can be improved by various therapeutic modalities. Clean intermittent catheterization is recommended for patients with significant increased postvoid residual volumes or urinary retention. Although pharmacotherapy such as with alpha-blockers or parasympathomimetics can be considered for UAB, there is insufficient evidence of their effect on incontinence with UAB. Future therapies, such as stem cell therapy or gene therapy, may be used to treat incontinence with UAB. The possibility of management urgency urinary incontinence that related to detrusor hyperactivity with impaired contractility using sacral neuromodulation has been suggested. Further research is needed to establish evidence for the efficacy and safety of treatments for incontinence with UAB and improve patient quality of life.

Authors+Show Affiliations

Department of Urology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.Department of Urology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32615672

Citation

Cho, Kang Jun, and Joon Chul Kim. "Management of Urinary Incontinence With Underactive Bladder: a Review." International Neurourology Journal, vol. 24, no. 2, 2020, pp. 111-117.
Cho KJ, Kim JC. Management of Urinary Incontinence With Underactive Bladder: A Review. Int Neurourol J. 2020;24(2):111-117.
Cho, K. J., & Kim, J. C. (2020). Management of Urinary Incontinence With Underactive Bladder: A Review. International Neurourology Journal, 24(2), 111-117. https://doi.org/10.5213/inj.2040076.038
Cho KJ, Kim JC. Management of Urinary Incontinence With Underactive Bladder: a Review. Int Neurourol J. 2020;24(2):111-117. PubMed PMID: 32615672.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Management of Urinary Incontinence With Underactive Bladder: A Review. AU - Cho,Kang Jun, AU - Kim,Joon Chul, Y1 - 2020/06/30/ PY - 2020/03/06/received PY - 2020/04/16/accepted PY - 2020/7/4/entrez PY - 2020/7/4/pubmed PY - 2020/7/4/medline KW - Therapeutics KW - Urinary bladder, underactive KW - Urinary incontinence SP - 111 EP - 117 JF - International neurourology journal JO - Int Neurourol J VL - 24 IS - 2 N2 - Urinary incontinence is caused by storage function failure, while underactive bladder (UAB) is caused by a decline in detrusor contractility and voiding dysfunction. As the treatment mechanisms for incontinence and UAB are contrary to each other, it is difficult to treat both incontinence and UAB, and the patient's quality of life can be further degraded. Conventional midurethral sling (MUS), such as transobturator tape or retropubic MUS, introduces a risk of postoperative voiding dysfunction in stress urinary incontinence with UAB. However, there have been several reports about the efficacy and safety of conventional MUS. Adjustable sling procedures, such as transobturator adjustable tape or the Remeex system, have better outcomes than conventional MUS because they control tension both during and after surgery. When voiding dysfunction occurs after incontinence treatment with UAB, voiding symptoms can be improved by various therapeutic modalities. Clean intermittent catheterization is recommended for patients with significant increased postvoid residual volumes or urinary retention. Although pharmacotherapy such as with alpha-blockers or parasympathomimetics can be considered for UAB, there is insufficient evidence of their effect on incontinence with UAB. Future therapies, such as stem cell therapy or gene therapy, may be used to treat incontinence with UAB. The possibility of management urgency urinary incontinence that related to detrusor hyperactivity with impaired contractility using sacral neuromodulation has been suggested. Further research is needed to establish evidence for the efficacy and safety of treatments for incontinence with UAB and improve patient quality of life. SN - 2093-4777 UR - https://www.unboundmedicine.com/medline/citation/32615672/Management_of_Urinary_Incontinence_With_Underactive_Bladder:_A_Review L2 - https://dx.doi.org/10.5213/inj.2040076.038 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.